THINH T TANG
Allopathic & Osteopathic Physicians|Internal Medicine LAS VEGAS, NV NPI 1588042444
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine NV ABBVIE INC. All categories
General Payments — all program years on this page
$9,036.60
- Category: General Payments
- Program years: PY2018–2024
- Record count: 302
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,205.30 across 76 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,613.92 | 74 |
| Travel and Lodging | $591.38 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $597.94 | 34 |
| Medtronic, Inc. | $591.38 | 2 |
| Gilead Sciences, Inc. | $187.44 | 4 |
| Janssen Biotech, Inc. | $144.86 | 4 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $118.97 | 5 |
| GENZYME CORPORATION | $109.40 | 4 |
| Regeneron Healthcare Solutions, Inc. | $65.40 | 3 |
| Lilly USA, LLC | $64.59 | 3 |
| AIMMUNE THERAPEUTICS, INC. | $52.11 | 2 |
| Organon LLC | $45.81 | 3 |
| QOL Medical, LLC | $37.97 | 2 |
| Madrigal Pharmaceuticals | $37.63 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $37.49 | 2 |
| IRONWOOD PHARMACEUTICALS, INC | $29.60 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $22.30 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $18.11 | 1 |
| Merck Sharp & Dohme Corporation | $16.53 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.13 | 1 |
| Braintree Laboratories, Inc. | $13.64 | 1 |
By program year
Records — PY2024 (76)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.